Successful treatment of porocarcinoma with maxacalcitol and imiquimod.

Abstract:

:This is the first report of a case of porocarcinoma that was successfully treated with maxacalcitol and imiquimod.

journal_name

Dermatol Ther

journal_title

Dermatologic therapy

authors

Nagasawa T,Hirata A,Niiyama S,Enomoto Y,Fukuda H

doi

10.1111/dth.12830

subject

Has Abstract

pub_date

2019-03-01 00:00:00

pages

e12830

issue

2

eissn

1396-0296

issn

1529-8019

journal_volume

32

pub_type

信件
  • Papulosquamous diseases in the elderly.

    abstract::This article refers to papulosquamous diseases that are seen in the elderly. Many of these diseases are complex to diagnose due to the fact that they are difficult to identify, because they may resemble a similar disorder, which can be misleading. The problem that is frequently seen with these diseases is that they ar...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1046/j.1529-8019.2003.01633.x

    authors: Norman RA,Blanco PM

    更新日期:2003-01-01 00:00:00

  • Rituximab as the treatment of pemphigus vulgaris in the COVID-19 pandemic era: A narrative review.

    abstract::Pemphigus vulgaris (PV), an autoimmune blistering disease is treated with immunosuppressive medications. As the immunosuppressive effect of rituximab, the first-line therapy of PV, lasts more than 6 months, many concerns have raised due to the ongoing novel coronavirus disease (COVID-19) pandemic. With this background...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.14405

    authors: Beyzaee AM,Rahmatpour Rokni G,Patil A,Goldust M

    更新日期:2020-10-13 00:00:00

  • Coping with the isotretinoin registry.

    abstract::The isotretinoin registry has arrived. It has a lofty goal of preventing all isotretinoin pregnancies. How we got to this point and what the registry means to prescribers and patients have many dermatologists confused and concerned. Will it be burdensome, will it preclude the use in most offices of this most important...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/j.1529-8019.2006.00080.x

    authors: Baldwin HE

    更新日期:2006-07-01 00:00:00

  • Management of cancer therapy-induced oral mucositis.

    abstract::The oral mucosa is a common site for collateral damage of cancer therapies, including radiation, cytotoxic medication, and newer targeted therapies. Ulcerative oral mucositis is typically painful and affects oral functions including speech, and oral intake of food and medications, thus impacting the quality of life. D...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/j.1529-8019.2011.01434.x

    authors: Barasch A,Epstein JB

    更新日期:2011-07-01 00:00:00

  • Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities.

    abstract::Basal cell carcinoma (BCC) is the most common malignancy in Caucasians, and its incidence is increasing. Most BCCs are treated surgically, nevertheless surgery is not an effective treatment for locally advanced or metastatic BCC. Alterations in hedgehog signaling pathway, a key regulator of cell growth and differentia...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13108

    authors: Spallone G,Sollena P,Ventura A,Fargnoli MC,Gutierrez C,Piccerillo A,Tambone S,Bianchi L,Peris K

    更新日期:2019-11-01 00:00:00

  • Efficacy and safety of risankizumab in psoriasis patients who failed anti-IL-17, anti-12/23 and/or anti IL-23: Preliminary data of a real-life 16-week retrospective study.

    abstract::Up until now, real-life experiences on the efficacy of risankizumab in patients who had previously failed anti-IL17, anti-IL12/23 or anti-IL23 inhibitor are not reported. We carried out a single-center, retrospective study, to evaluate the efficacy, safety and tolerability of patients under risankizumab who previously...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14144

    authors: Megna M,Fabbrocini G,Ruggiero A,Cinelli E

    更新日期:2020-11-01 00:00:00

  • Efficacy and tolerability of 20% aluminum sesquichlorohydrate vs 20% aluminum chloride for the treatment of axillary hyperhidrosis: A randomized controlled trial.

    abstract::This study evaluated the efficacy and tolerability of topical aluminum sesquichlorohydrate (AS) when compared to aluminum chloride (AC) as a treatment for primary axillary hyperhidrosis (PAH). Twenty subjects were included in this randomized, controlled, split-side 8-week study. All participants applied 20% AS and 20%...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14354

    authors: Thianboonsong T,Kanokrungsee S,Paichitrojjana A,Udompataikul M,Kamanamool N,Rojhirunsakool S

    更新日期:2020-11-01 00:00:00

  • Does therapy with biological drugs influence COVID-19 infection? Observational monocentric prevalence study on the clinical and epidemiological data of psoriatic patients treated with biological drugs or with topical drugs alone.

    abstract::Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, there has been an open debate on the impact of biological drugs used in the treatment of psoriasis. To define whether patients under treatment with biologics suffer from increased morbidity and mortality from COVID-19, compared to psoriatic patients ...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14516

    authors: Brazzelli V,Isoletta E,Barak O,Barruscotti S,Vassallo C,Giorgini C,Michelerio A,Tomasini CF,Musella V,Klersy C

    更新日期:2020-11-01 00:00:00

  • Unlocking the mystery of persistent skin ulcers in a young man and successful treatment with a simple regimen.

    abstract::Despite the high prevalence of pulmonary tuberculosis worldwide, extrapulmonary tuberculosis especially cutaneous and osteoarticular tuberculosis occurs rarely, both of which are often difficult to be recognized since their symptoms mimic those of many other cutaneous and osteoarticular diseases. Here, we present a ra...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.12600

    authors: Li Z,Wang S,Chen X,Ming X,Peng L,Li W

    更新日期:2018-07-01 00:00:00

  • The potential of probiotics for treating acne vulgaris: A review of literature on acne and microbiota.

    abstract::Acne is known as a chronic inflammatory skin disease with sever adverse effects on quality of life in the patients. The increasing resistance to antibiotics has decreased their effectiveness in treating acne. As viable microbial dietary supplements, probiotics provide health benefits through fighting pathogens and mai...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.13279

    authors: Goodarzi A,Mozafarpoor S,Bodaghabadi M,Mohamadi M

    更新日期:2020-05-01 00:00:00

  • Laser tattoo removal: Fundamental principles and practical approach.

    abstract::Tattoos have long become a part of human civilization. However, as the number of people who get tattoos increases, so is the number of people who wish to have their tattoos removed. Compared to other methods, laser-based devices are associated with the best efficacy and least side effects in tattoo removal. Lack of un...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.14418

    authors: Kurniadi I,Tabri F,Madjid A,Anwar AI,Widita W

    更新日期:2020-10-17 00:00:00

  • Use of Becaplermin for nondiabetic ulcers: pyoderma gangrenosum and calciphylaxis.

    abstract::Large difficult to heal ulcers of various etiologies carry a high morbidity and mortality rate. Becaplermin is a recombinant platelet-derived growth factor approved for treatment of diabetic ulcers. In this two-case series, we report the use of becaplermin in the treatment of ulcers due to (i) calciphylaxis, an often ...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.12318

    authors: Twu O,Mednik S,Scumpia P,Doaty S,Worswick S

    更新日期:2016-03-01 00:00:00

  • Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?

    abstract::Psoriasis is a chronic inflammatory condition that often requires life-long treatment. Conventional therapies have not fully met the needs of psoriatic patients, because of limited efficacy, adverse effects with cumulative use, and patient inconvenience. In the past decade, biologic immunotherapies have become accepte...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/j.1529-8019.2009.01259.x

    authors: Alwawi EA,Krulig E,Gordon KB

    更新日期:2009-09-01 00:00:00

  • Psoriatic arthritis.

    abstract::Although there is still some controversy about the existence of psoriatic arthritis as a specific form of inflammatory arthritis associated with psoriasis, epidemiological, and clinical studies support the unique features of psoriatic arthritis. Because of lack of diagnostic or classification criteria, the disease has...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/j.1396-0296.2004.04038.x

    authors: Gladman DD

    更新日期:2004-01-01 00:00:00

  • Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.

    abstract::Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous reactions that are medication-induced in most instances. While the clinical manifestations of SJS and TEN are well-defined, the optimal treatment for these disorders is not. Case reports have shown benefit with the use of a variet...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/j.1529-8019.2011.01396.x

    authors: Worswick S,Cotliar J

    更新日期:2011-03-01 00:00:00

  • An analysis of cumulative lifetime solar ultraviolet radiation exposure and the benefits of daily sun protection.

    abstract::Cumulative exposure to ultraviolet radiation (UVR) increases the risk of developing skin cancer, particularly squamous cell carcinoma and basal cell carcinoma. Thus, the need for protection from the sun is widely advocated, but consumers generally associate such protection with the occasional extreme exposure and tend...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/j.1396-0296.2004.04s1007.x

    authors: Nole G,Johnson AW

    更新日期:2004-01-01 00:00:00

  • Adverse electrocardiographic effects of rituximab infusion in pemphigus patients.

    abstract::Pemphigus encompasses a group of chronic autoimmune blistering diseases of the skin and/or mucosa. Rituximab (RTX) has shown promising efficacy for the treatment of pemphigus in the past decade. Considering potential cardiac side effects, this study was conducted to assess the effects of RTX on electrocardiogram (ECG)...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14299

    authors: Aidi S,Daneshpazhooh M,Eslami M,Azizpour A,Toosi R,Mollazadeh R

    更新日期:2020-11-01 00:00:00

  • Trichobiolight®: A New, Effective Protocol in The Treatment of Androgenetic Alopecia and Telogen Effluvium.

    abstract:INTRODUCTION:Androgenetic Alopecia (AGA) with its precursor Miniaturization of Anagen phase (MA), and Telogen Effluvium (TE) represent non-scarring hair loss diseases which causes moderate to severe aesthetic and psychologic discomfort in affected people. Several therapeutic approaches have been tested through the late...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14799

    authors: Piccolo D,Crisman G,Conforti C,Buzzi M,Genovesi C,Marchi D,Mazzaracchio D,Goldust M

    更新日期:2021-01-24 00:00:00

  • Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4.

    abstract::In the past decade, the expanded use of targeted anticancer drugs has significantly prolonged survival in patients treated for a variety of cancers. Despite their increased specificity, agents such as epidermal growth factor receptor inhibitors (EGFRIs), BRAF inhibitors, and targeted immunotherapies have commonly been...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.12027

    authors: Fischer A,Rosen AC,Ensslin CJ,Wu S,Lacouture ME

    更新日期:2013-03-01 00:00:00

  • Self-administered daylight-activated photodynamic therapy for the treatment of hand eczema: A prospective proof-of-concept study.

    abstract::Photodynamic therapy (PDT), traditionally used in patients with nonmelanoma skin cancer, has been found to be effective for various inflammatory skin conditions. Daylight-activated PDT (DL-PDT), in which the sun serves as the light source, is substantially less painful than conventional PDT. This study aimed to determ...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14329

    authors: Kremer N,Sherman S,Lapidoth M,Enk CD,Leshem YA,Mimouni T,Dudkiewicz D,Hodak E,Levi A

    更新日期:2020-11-01 00:00:00

  • Refractory palmoplantar pustulosis succesfully treated with apremilast.

    abstract::Palmoplantar pustulosis is a chronic inflammatory disease which characterized by a eruption of sterile pustules on the palms and soles. Apremilast is an oral phosphodiesterase-4 inhibitor which is approved for the treatment of chronic plaque psoriasis and psoriatic arthritis. However, no clinical trial has been perfor...

    journal_title:Dermatologic therapy

    pub_type: 信件

    doi:10.1111/dth.13230

    authors: Carrascosa de Lome R,Conde Montero E,de la Cueva Dobao P

    更新日期:2020-03-01 00:00:00

  • Therapeutic options in vitiligo with special emphasis on immunomodulators: A comprehensive update with review of literature.

    abstract::Vitiligo is a relatively common disorder characterized by areas of depigmented skin. It may be associated with social stigma and adversely affects the quality of life. Although many treatment options are available, none is curable. The search continues for an effective therapeutic option. New targeted options include ...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.13215

    authors: Agarwal K,Podder I,Kassir M,Vojvodic A,Schwartz RA,Wollina U,Valle Y,Lotti T,Rokni GR,Grabbe S,Goldust M

    更新日期:2020-03-01 00:00:00

  • Clinical research in dermatology: 10 steps to getting started.

    abstract::Clinical research plays a very important role in the development of drugs and devices, including those for wound healing. The process of initiating a clinical trial can be rather daunting, particularly with the ever-increasing regulatory hurdles. Many clinicians are generally either not trained or have limited knowled...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/j.1529-8019.2006.00095.x

    authors: Carson PA

    更新日期:2006-11-01 00:00:00

  • Investigation of pregnancy associated plasma protein-A and neopterin levels in Behçet's patients.

    abstract::Behçet's disease (BD) is an autoimmune disease that affects many organs. We aimed to investigate the relationship between BD and these pregnancy-associated plasma protein A (PAPP-A), neopterin, and high sensitive C-reactive protein (hsCRP) parameters. The study included 57 BD patients and 54 healthy controls. After ev...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13443

    authors: Akyurek F,Tuncez Akyurek F

    更新日期:2020-07-01 00:00:00

  • A comparison of Myribase and Doublebase gel: Does qualitative similarity of emollient products imply their direct interchangeability in everyday practice?

    abstract::Emollients are acknowledged as a part of standard care in therapeutic and prevention protocols as well as a part of everyday skin care routine. When it comes to making a final decision between two emollient products, the ingredient list, that is, the formulation composition could be the determining factor. In such cas...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14020

    authors: Lukic M,Pantelic I,Savic S

    更新日期:2020-11-01 00:00:00

  • Dressings for chronic wounds.

    abstract::Covering wounds, acute and chronic, is one of the most fundamental activities of any medical practitioner. Although wound dressings primarily serve to contain the "good" and keep out the "bad," research has characterized more specifically the sophisticated interaction between the human wound bed and its dressing count...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.12055

    authors: Powers JG,Morton LM,Phillips TJ

    更新日期:2013-05-01 00:00:00

  • Short- and long-term effects of two emollients on itching and skin restoration in xerotic eczema.

    abstract::Pruritus is associated with various skin diseases, dry skin, and with it an impaired skin barrier function. The study objective was to investigate short-term and long-term effects of two emollients on symptoms and skin barrier functions in xerotic eczema. Randomized, double-blind, study enrolling females/males, with b...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1111/dth.12692

    authors: Simon D,Nobbe S,Nägeli M,Barysch M,Kunz M,Borelli S,Hasan-Ali O,Wildi E,Gasser UE

    更新日期:2018-11-01 00:00:00

  • Fractional CO2 laser: a novel therapeutic device upon photobiomodulation of tissue remodeling and cytokine pathway of tissue repair.

    abstract::Minimally ablative fractional laser devices have gained acceptance as a preferred method for skin resurfacing. Notable improvements in facial rhytides, photodamage, acne scarring, and skin laxity have been reported. The aim of the present work was to compare how different CO(2) laser fluences, by modulating the secret...

    journal_title:Dermatologic therapy

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1529-8019.2009.01265.x

    authors: Prignano F,Campolmi P,Bonan P,Ricceri F,Cannarozzo G,Troiano M,Lotti T

    更新日期:2009-11-01 00:00:00

  • Luliconazole-loaded nanostructured lipid carriers for topical treatment of superficial Tinea infections.

    abstract::Tinea are superficial fungal infections caused by dermatophytes. Luliconazole exhibits highest antifungal activity against Trichophyton spp. which are major causative agents of dermatophytosis. However, luliconazole suffers from drawbacks such as less skin retention, low aqueous solubility and poor skin penetration. T...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13959

    authors: Baghel S,Nair VS,Pirani A,Sravani AB,Bhemisetty B,Ananthamurthy K,Aranjani JM,Lewis SA

    更新日期:2020-11-01 00:00:00

  • Clinical efficacy of dialkylcarbamoylchloride-coated cotton acetate dressing versus combination of normal saline dressing and 2% mupirocin ointment in infected wounds of epidermolysis bullosa.

    abstract::Dialkylcarbamoylchloride (DACC)-coated cotton acetate dressing works directly through hydrophobic interaction to reduce the number of bacteria without the risk of resistance. It is easy to use and therefore expected to improve patient's compliance. This study aimed to assess the clinical efficacy of DACC-coated cotton...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13047

    authors: Dwiyana RF,Gondokaryono SP,Rahardja JI,Arline Diana I,Yogya Y,Gunawan H

    更新日期:2019-09-01 00:00:00